527
Views
47
CrossRef citations to date
0
Altmetric
Review Article

The role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acids

Pages 342-350 | Received 28 Apr 2016, Accepted 27 May 2016, Published online: 30 Jun 2016

References

  • Abel J, Li W, D ṏõhr O. (1996). Dose-response relationship of cytochrome P4501b1 mRNA induction by 2,3,7,8-tetrachlorodibenzo-p-dioxin in livers of C57BL/6J and DBA/2J mice. Arch Toxicol 70:510–513.
  • Androutsopoulos VP, Tsatsakis AM, Spandidos DA. (2009). Cytochrome P450 CYP1A1: Wider roles in cancer progression and prevention. BMC Cancer 9:187.
  • Bessede A, Gargaro M, Pallotta M. (2014). Aryl hydrocarbon receptor control of a disease tolerance defence pathway. Nature 511:184–190.
  • Boutros PC, Yan R, Moffatt ID. (2008). Transcriptomic responses to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in liver: comparison of rat and mouse. BMC Genomics 9:419.
  • Buczynski MW, Dumlao DS, Dennis EA. (2009). Thematic review series: Proteomics. An integrated omics analysis of eicosanoid biology. J Lipid Res 50:1015–1038.
  • Bui P, Solaimani P, Wu X. (2012). 2,3,7,8-Tetrachlorodibenzo-p-dioxin treatment alters eicosanoid levels in several organs of the mouse in an aryl hydrocarbon receptor-dependent fashion. Toxicol Appl Pharmacol 259:143–151.
  • Choudhary D, Jansson I, Stoilov I. (2004). Metabolism of retinoids and arachidonic acid by human and mouse cytochrome P450 1b1. Drug Metab Dispos 32:840–847.
  • Dalton TP, Kerzee JK, Wang B. (2001). Dioxin exposure is an environmental risk factor for ischemic heart disease. Cardiovasc Toxicol 1:285–298.
  • Denison MS, Soshilov AA, He G. (2011). Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol Sci 124:1–22.
  • Diani-Moore S, Ma Y, Gross SS. (2014). Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. Drug Metabol Dispos 42:294–300.
  • Feng S, Cao Z, Wang X. (2013). Role of aryl hydrocarbon receptor in cancer. Biochim Biophys Acta 1836:197–210.
  • Fer M, Dreano Y, Lucas D. (2008). Metabolism of eicosapentaenoic and docosahexaenoic acids by recombinant human cytochromes P450. Arch Biochem Biophys 471:116–125.
  • Fontana RJ, Lown KS, Paine MF. (1999). Effects of a chargrilled meat diet on expression of CYP3A, CYP1A, and P-glycoprotein levels in healthy volunteers. Gastroenterology 117:89–98.
  • Forgacs AL, Kent MN, Makley MK. (2012). Comparative metabolomic and genomic analyses of TCDD-elicited metabolic disruption in mouse and rat liver. Toxicol Sci 125:41–55.
  • Gasiewicz TA, Henry EC. (2011). History of research on the AHR. In: Pohjanvirta R, ed. The AH receptor in biology and toxicology. Hoboken (NJ): Wiley, 3–32.
  • Hankinson O. (1995). The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307–340.
  • Hankinson O. (2012) The AHR/ARNT dimer and transcriptional coactivators. In Pohjanvirta R, ed. The AH receptor in biology and toxicology. Hoboken (NJ): John Wiley & Sons, Inc. 93–100.
  • Harper PA, Riddick DS, Okey AB. (2006). Regulating the regulator: Factors that control levels and activity of the aryl hydrocarbon receptor. Biochem Pharmacol 72:267–279.
  • Hayes KR, Zastrow GM, Nukaya M. (2007). Hepatic transcriptional networks induced by exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chem Res Toxicol 20:1573–1581.
  • Jiang JG, Ning YG, Chen C. (2007). Cytochrome p450 epoxygenase promotes human cancer metastasis. Cancer Res 67:6665–6674.
  • Kinehara M, Fukuda I, Yoshida K, Ashida H. (2009). Aryl hydrocarbon receptor-mediated induction of the cytosolic phospholase A(2)alpha gene by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mouse hepatoma Hepa-1c1c7 cells. J Biosci Bioeng 108:277–281.
  • Kita Y, Ohto T, Uozumi N, Shimizu T. (2006). Biochemical properties and pathophysiological roles of cytosolic phospholipase A2s. Biochimica Et Biophysica Acta 1761:1317–1322.
  • Kopec AK, Burgoon LD, Ibrahim-Aibo D. (2010). Automated dose-response analysis and comparative toxicogenomic evaluation of the hepatic effects elicited by TCDD, TCDF, and PCB126 in C57BL/6 mice. Toxicol Sci 118:286–297.
  • Kopec AK, D’Souza ML, Mets BD. (2011). Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice. Toxicol Appl Pharmacol 256:154–167.
  • Lin S, Yang Z, Liu H, Cai Z. (2011). Metabolomic analysis of liver and skeletal muscle tissues in C57BL/6J and DBA/2J mice exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Mol Biosyst 7:1956–1965.
  • Moura-Alves P, Fae K, Houthuys E. (2014). AhR sensing of bacterial pigments regulates antibacterial defence. Nature 512:387–392.
  • Norwood S, Liao J, Hammock BD. (2010). Epoxyeicosatrienoic acids and soluble epoxide hydrolase: Potential therapeutic targets for inflammation and its induced carcinogenesis. Am J Transl Res 2:447–457.
  • Opitz CA, Litzenburger UM, Sahm F. (2011). An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor. Nature 478:197–203.
  • Panigrahy D, Edin ML, Lee CR. (2012). Epoxyeicosanoids stimulate multiorgan metastasis and tumor dormancy escape in mice. J Clin Invest 122:178–191.
  • Pozzi A, Ibanez MR, Gatica AE. (2007). Peroxisomal proliferator-activated receptor-alpha-dependent inhibition of endothelial cell proliferation and tumorigenesis. J Biol Chem 282:17685–17695.
  • Pozzi A, Popescu V, Yang S. (2010). The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated. J Biol Chem 285:12840–12850.
  • Rifkind AB. (2006). CYP1A in TCDD toxicity and in physiology-with particular reference to CYP dependent arachidonic acid metabolism and other endogenous substrates. Drug Metab Rev 38:291–335.
  • Schlezinger JJ, Parker C, Zeldin DC, Stegeman JJ. (1998). Arachidonic acid metabolism in the marine fish Stenotomus chrysops (Scup) and the effects of cytochrome P450 1A inducers. Arch Biochem Biophys 353:265–275.
  • Schwarz D, Kisselev P, Ericksen SS. (2004). Arachidonic and eicosapentaenoic acid metabolism by human CYP1A1: Highly stereoselective formation of 17(R),18(S)-epoxyeicosatetraenoic acid. Biochem Pharmacol 67:1445–1457.
  • Spector AA, Kim HY. (2015). Cytochrome P540 epoxygenase pathway of polyunsaturated fatty acid metabolism. Biochimica Biophysica Acta 1851:356–365.
  • Stejskalova L, Pavek P. (2011). The function of cytochrome P450 1A1 enzyme (CYP1A1) and aryl hydrocarbon receptor (AhR) in the placenta. Curr Pharm Biotechnol 12:715–730.
  • Vogel C, Schuhmacher US. Degen GH. (1998). Modulation of prostaglandin H Synthase-2 mRNA expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin in mice. Arch Biochem Biophys 352:265–271.
  • Yang J, Solaimani P, Dong H. (2013). Treatment of mice with 2,3,7,8-Tetrachlorodibenzo-p-dioxin markedly increases the levels of a number of cytochrome P450 metabolites of omega-3 polyunsaturated fatty acids in the liver and lung. J Toxicol Sci 38:833–836.
  • Zhang G, Panigraphy D, Mahakian LM. (2013). Epoxy metabolites of docosahexaenoic acid (DHA) inhibit angiogenesis, tumor growth, and metastasis. Proc Natl Acad Sci USA 110:6530–6535.
  • Zhang G, Panigraphy D, Hwang SH. (2014). Dual inhibition of cyclooxygenase-2 and soluble epoxide hydrolase synergistically suppresses primary tumor growth and metastasis. Proc Natl Acad Sci USA 111:11127–11132. PMCID: PMC4121808.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.